CUBIST PHARMACEUTICALS INC Operating Cash Flow
CUBIST PHARMACEUTICALS INC reported Operating Cash Flow of $92.25 million for the 6-month period ending 2011-06-30, per its 10-Q filed 2011-07-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2011-07-29
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was $81.73M, a 5.44% increase year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-03-31 was $10.52M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2010-12-31 was $73.28M, a 14.17% increase year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2010-09-30 was $40.66M, a 4.79% increase year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was $184.47M, a 15.47% increase from fiscal 2009.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2009 was $159.76M, a 30.75% increase from fiscal 2008.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2008 was $122.19M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2011-06-30 | $81.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | $92.25M 10-Q · filed 2011-07-29 | $165.54M derived: sum of 3 quarters · filed 2011-07-29 | $206.20M derived: sum of 4 quarters · filed 2011-07-29 |
| 2011-03-31 | $10.52M 10-Q · filed 2011-04-29 | $83.80M derived: sum of 2 quarters · filed 2011-04-29 | $124.47M derived: sum of 3 quarters · filed 2011-04-29 | $201.98M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-12-31 | $73.28M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-23 | $113.94M derived: sum of 2 quarters · filed 2011-02-23 | $191.46M derived: sum of 3 quarters · filed 2011-07-29 | $184.47M 10-K · filed 2011-02-23 |
| 2010-09-30 | $40.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $118.18M derived: sum of 2 quarters · filed 2011-07-29 | $111.19M 10-Q · filed 2010-10-29 | $175.38M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-06-30 | $77.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | $70.53M 10-Q · filed 2011-07-29 | $134.72M derived: sum of 3 quarters · filed 2011-07-29 | $173.52M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-03-31 | -$6.99M 10-Q · filed 2011-04-29 | $57.20M derived: sum of 2 quarters · filed 2011-04-29 | $96.00M derived: sum of 3 quarters · filed 2011-04-29 | |
| 2009-12-31 | $64.19M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-23 | $102.99M derived: sum of 2 quarters · filed 2011-02-23 | $159.76M 10-K · filed 2011-02-23 | |
| 2009-09-30 | $38.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $95.58M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $56.77M 10-Q · filed 2010-07-30 | |||
| 2008-12-31 | $122.19M 10-K · filed 2011-02-23 |